Tag: SNA Vaccine Works

Flashpoint Therapeutics, a clinical-stage biotechnology company pioneering structural nanomedicines, has announced a peer-reviewed publication in Science Advances demonstrating the effectiveness of its Spherical Nucleic Acid (SNA) vaccine platform against HPV-related cancers. The study, led by Professor Chad A. Mirkin, co-founder of Flashpoint and Director of the International Institute for Nanotechnology at Northwestern University, describes a…